Correlates of protection against SIV/SHIV challenge
Correlates of protection against SIV/SHIV challenge
批准号:
7645935
负责人:
Hildegund C. J. Ertl
金额:
$283.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2011-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
_________________________________________________________________________________________
It is the primary objective of this program to elucidate correlates of immune-mediated protection against HIV-1 infection using pre-clinical animal models. To this end, Project 1 will determine humoral and cell-mediated immune responses to an attenuated SIV, termed SIVGY that induces protective immunity to subsequent challenge with a heterologous pathogenic SIV. Project 3 will determine immune responses elicited by different prime-boost vaccine regimens using combinations of DNA vaccines, E1-deleted adenovirus (Ad) vectors and poxvirus vectors. Project 2 will use passive immunization with neutralizing antibodies to determine baseline parameters of antibody-mediated protection with the long-term to develop vaccines that induce B and T cells. Project 3 will assess the role of vaccine-induced mucosal T cells in limiting the spread of SIV. It is the secondary objective of this program to determine if vaccine-induced immune responses including those induced by Ad vectors can be detrimental and if further modifications of E1-deleted Ad vectors can improve both their safety and immunogenicity/efficacy. To this end, Project 3 will test the hypothesis that CD4+ T cell responses induced by viral vector vaccines against the transgene product or components of the vector facilitate disease progression upon SIV infection of nonhuman primates. Project 1 will attempt to improve the efficacy and safety profile of Ad vector vaccines by generating and testing 2nd generation E1-deleted Ad vectors that will have an additional deletion of E2a to reduce synthesis of the highly immunogenic structural antigens of Ad vectors. The application is subdivided into the following 3 Projects and 2 Cores. Project 1 (H. Ertl): Vaccine-Induced Correlates of Protection Project 2 (R. Ruprecht): Neutralizing Antibody Coverage for CTL Vaccines Project 3 (G. Silvestri): Mucosal T Cell Responses and Protection from Simian AIDS Core A (H. Ertl): Administrative Core Core B (X. Zhou): Vector Core
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
-
批准号:7789929
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:Hildegund C. J. Ertl
-
依托单位:
GENE REPLACEMENT THERAPY AND THE IMMUNE SYSTEM
-
批准号:7885360
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2009
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Correlates of protection against SIV/SHIV challenge
-
批准号:7924012
-
项目类别:
-
资助金额:$274.92万
-
财政年份:2009
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Administrative Core
-
批准号:7694087
-
项目类别:
-
资助金额:$13.66万
-
财政年份:2008
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Clinical Development of Chimp Adenovirus Vectors
-
批准号:7681726
-
项目类别:
-
资助金额:$133.71万
-
财政年份:2008
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors
-
批准号:7681727
-
项目类别:
-
资助金额:$73.69万
-
财政年份:2008
-
负责人:Hildegund C. J. Ertl
-
依托单位:
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
-
批准号:7268595
-
项目类别:
-
资助金额:$256.94万
-
财政年份:2007
-
负责人:Hildegund C. J. Ertl
-
依托单位:
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
-
批准号:8514890
-
项目类别:
-
资助金额:$215.51万
-
财政年份:2007
-
负责人:Hildegund C. J. Ertl
-
依托单位:
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
-
批准号:7925783
-
项目类别:
-
资助金额:$304.17万
-
财政年份:2007
-
负责人:Hildegund C. J. Ertl
-
依托单位:
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
-
批准号:8137913
-
项目类别:
-
资助金额:$202.36万
-
财政年份:2007
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors
-
批准号:7280615
-
项目类别:
-
资助金额:$78.3万
-
财政年份:2007
-
负责人:Hildegund C. J. Ertl
-
依托单位:
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
-
批准号:7488408
-
项目类别:
-
资助金额:$286.14万
-
财政年份:2007
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Administrative Core
-
批准号:7280618
-
项目类别:
-
资助金额:$15.33万
-
财政年份:2007
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Clinical Development of Chimp Adenovirus Vectors
-
批准号:7280611
-
项目类别:
-
资助金额:$93.43万
-
财政年份:2007
-
负责人:Hildegund C. J. Ertl
-
依托单位:
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
-
批准号:7681730
-
项目类别:
-
资助金额:$509.26万
-
财政年份:2007
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Immune Responses To AAV-Mediated FIX Gene Transfer
-
批准号:6960295
-
项目类别:
-
资助金额:$163.59万
-
财政年份:2005
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Administrative Core
-
批准号:8375435
-
项目类别:
-
资助金额:$7.33万
-
财政年份:2005
-
负责人:Hildegund C. J. Ertl
-
依托单位:
T Cells To AAV And AAV-Encoded Transgene Products
-
批准号:8282764
-
项目类别:
-
资助金额:$41.6万
-
财政年份:2005
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Administrative Core
-
批准号:8690944
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2005
-
负责人:Hildegund C. J. Ertl
-
依托单位:
Immune Responses To AAV-Mediated FIX Gene Transfer
-
批准号:7105594
-
项目类别:
-
资助金额:$160.36万
-
财政年份:2005
-
负责人:Hildegund C. J. Ertl
-
依托单位:
国内基金
海外基金
加密/签名的密钥泄露保护机制研究
-
批准号:60970111
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2009
-
负责人:陈克非
-
依托单位: